Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lens proteins, primarily crystallins (α, β, and γ), are highly concentrated structural proteins in the eye lens responsible for maintaining transparency and refractive index. α-Crystallins act as molecular chaperones, preventing denaturation and aggregation of other lens proteins, crucial for long-term lens clarity. Failure of these protective mechanisms leads to cataracts. Therapeutic strategies focus on enhancing chaperone activity or mimicking their effects, and compounds like pyruvate have shown promise in preventing oxidative denaturation.
Enhancing chaperone activity, preventing oxidative damage, stabilizing protein structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lens Proteins.